163 related articles for article (PubMed ID: 36975376)
41. Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer.
Tang Z; Du R; Jiang S; Wu C; Barkauskas DS; Richey J; Molter J; Lam M; Flask C; Gerson S; Dowlati A; Liu L; Lee Z; Halmos B; Wang Y; Kern JA; Ma PC
Br J Cancer; 2008 Sep; 99(6):911-22. PubMed ID: 19238632
[TBL] [Abstract][Full Text] [Related]
42. Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR/Src/PAK1 pathway in lung adenocarcinoma.
Jin R; Wang X; Zang R; Liu C; Zheng S; Li H; Sun N; He J
Cancer Lett; 2020 Jul; 483():46-58. PubMed ID: 32272148
[TBL] [Abstract][Full Text] [Related]
43. Crosstalk between AhR and wnt/β-catenin signal pathways in the cardiac developmental toxicity of PM2.5 in zebrafish embryos.
Zhang H; Yao Y; Chen Y; Yue C; Chen J; Tong J; Jiang Y; Chen T
Toxicology; 2016 Apr; 355-356():31-8. PubMed ID: 27216425
[TBL] [Abstract][Full Text] [Related]
44. Fine particulate matter-induced lung inflammation is mediated by pyroptosis in mice.
Li J; An Z; Song J; Du J; Zhang L; Jiang J; Ma Y; Wang C; Zhang J; Wu W
Ecotoxicol Environ Saf; 2021 Aug; 219():112351. PubMed ID: 34029838
[TBL] [Abstract][Full Text] [Related]
45. The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer.
Smith DL; Acquaviva J; Sequeira M; Jimenez JP; Zhang C; Sang J; Bates RC; Proia DA
Target Oncol; 2015 Jun; 10(2):235-45. PubMed ID: 25077897
[TBL] [Abstract][Full Text] [Related]
46. Fine Particulate Matter-Induced Exacerbation of Allergic Asthma via Activation of T-cell Immunoglobulin and Mucin Domain 1.
Zhao YX; Zhang HR; Yang XN; Zhang YH; Feng S; Yu FX; Yan XX
Chin Med J (Engl); 2018 Oct; 131(20):2461-2473. PubMed ID: 30334531
[TBL] [Abstract][Full Text] [Related]
47. Loss of E-cadherin due to road dust PM
Tung NT; Ho KF; Niu X; Sun J; Shen Z; Wu F; Cao J; Dung HB; Thuy TPC; Hsiao TC; Liu WT; Chuang HC
Environ Sci Pollut Res Int; 2021 Oct; 28(38):53872-53887. PubMed ID: 34036507
[TBL] [Abstract][Full Text] [Related]
48. Leukocyte Cell-Derived Chemotaxin 2 Retards Non-Small Cell Lung Cancer Progression Through Antagonizing MET and EGFR Activities.
Hung WY; Chang JH; Cheng Y; Chen CK; Chen JQ; Hua KT; Cheng CW; Hsiao M; Chung CL; Lee WJ; Chien MH
Cell Physiol Biochem; 2018; 51(1):337-355. PubMed ID: 30453282
[TBL] [Abstract][Full Text] [Related]
49. Aldolase A promotes proliferation and G
Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
[TBL] [Abstract][Full Text] [Related]
50. Androgen-Induced TMPRSS2 Activates Matriptase and Promotes Extracellular Matrix Degradation, Prostate Cancer Cell Invasion, Tumor Growth, and Metastasis.
Ko CJ; Huang CC; Lin HY; Juan CP; Lan SW; Shyu HY; Wu SR; Hsiao PW; Huang HP; Shun CT; Lee MS
Cancer Res; 2015 Jul; 75(14):2949-60. PubMed ID: 26018085
[TBL] [Abstract][Full Text] [Related]
51. A novel EGFR inhibitor suppresses survivin expression and tumor growth in human gefitinib-resistant EGFR-wild type and -T790M non-small cell lung cancer.
Wang SP; Hsu YP; Chang CJ; Chan YC; Chen CH; Wang RH; Liu KK; Pan PY; Wu YH; Yang CM; Chen C; Yang JM; Liang MC; Wong KK; Chao JI
Biochem Pharmacol; 2021 Nov; 193():114792. PubMed ID: 34597670
[TBL] [Abstract][Full Text] [Related]
52. PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming.
Chen Q; Wang Y; Yang L; Sun L; Wen Y; Huang Y; Gao K; Yang W; Bai F; Ling L; Zhou Z; Zhang X; Xiong J; Zhai R
J Exp Clin Cancer Res; 2022 Jul; 41(1):229. PubMed ID: 35869499
[TBL] [Abstract][Full Text] [Related]
53. LncRNA LCPAT1 Mediates Smoking/ Particulate Matter 2.5-Induced Cell Autophagy and Epithelial-Mesenchymal Transition in Lung Cancer Cells via RCC2.
Lin H; Zhang X; Feng N; Wang R; Zhang W; Deng X; Wang Y; Yu X; Ye X; Li L; Qian Y; Yu H; Qian B
Cell Physiol Biochem; 2018; 47(3):1244-1258. PubMed ID: 29913439
[TBL] [Abstract][Full Text] [Related]
54. Potential lung carcinogenicity induced by chronic exposure to PM
Hu X; Li Q; Shao S; Zeng Q; Jiang S; Wu Q; Jiang C
Environ Sci Pollut Res Int; 2017 Aug; 24(23):18991-19000. PubMed ID: 28656580
[TBL] [Abstract][Full Text] [Related]
55. Acquired Resistance to EGFR TKIs Mediated by TGFβ1/Integrin β3 Signaling in EGFR-Mutant Lung Cancer.
Wang C; Wang T; Lv D; Li L; Yue J; Chen HZ; Xu L
Mol Cancer Ther; 2019 Dec; 18(12):2357-2367. PubMed ID: 31501278
[TBL] [Abstract][Full Text] [Related]
56. Fine particulate matter increases airway hyperresponsiveness through kallikrein-bradykinin pathway.
Cao X; Wang M; Li J; Luo Y; Li R; Yan X; Zhang H
Ecotoxicol Environ Saf; 2020 Jun; 195():110491. PubMed ID: 32213367
[TBL] [Abstract][Full Text] [Related]
57. Airway hyperresponsiveness development and the toxicity of PM2.5.
Lu X; Li R; Yan X
Environ Sci Pollut Res Int; 2021 Feb; 28(6):6374-6391. PubMed ID: 33394441
[TBL] [Abstract][Full Text] [Related]
58. PM2.5 exposure significantly improves the exacerbation of A549 tumor-bearing CB17-SCID mice.
Yang B; Xiao C
Environ Toxicol Pharmacol; 2018 Jun; 60():169-175. PubMed ID: 29730225
[TBL] [Abstract][Full Text] [Related]
59. Arsenic circumvents the gefitinib resistance by binding to P62 and mediating autophagic degradation of EGFR in non-small cell lung cancer.
Mao J; Ma L; Shen Y; Zhu K; Zhang R; Xi W; Ruan Z; Luo C; Chen Z; Xi X; Chen S
Cell Death Dis; 2018 Sep; 9(10):963. PubMed ID: 30237564
[TBL] [Abstract][Full Text] [Related]
60. microRNA-802/Rnd3 pathway imposes on carcinogenesis and metastasis of fine particulate matter exposure.
Li X; Lv Y; Gao N; Sun H; Lu R; Yang H; Zhang C; Meng Q; Wu S; Li AQ; Xia Y; Chen R
Oncotarget; 2016 Jun; 7(23):35026-43. PubMed ID: 27144337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
